Abstract
There is an on-going debate about the best drug-eluting stent (DES) for patients with Diabetes Mellitus (DM). To date, there are no comparisons between everolimus-eluting stents (EES) and resolute zotarolimus-eluting stents (R-ZES) in patients with DM and MVD. The objective was to compare the safety
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
